小柯机器人

研究解析出与细胞因子释放抑制剂CRID3结合的NLRP3十聚体结构
2022-02-11 10:54

德国波恩大学Matthias Geyer研究小组解析出与细胞因子释放抑制剂CRID3结合的NLRP3十聚体结构。2022年2月3日,《自然》杂志在线发表了这项成果。

研究人员报告了全长人类NLRP3的初始形式和与抑制剂CRID3(也被命名为MCC950)结合的冷冻电镜结构。失效的、与ADP结合的NLRP3是一个十聚体的,由交织在一起的LRR结构域组成的同源二聚体,背靠背组装成五聚体。NACHT结构位于这个球形结构的顶端轴。另外,在LRR笼内还形成了一个PYD二聚体。两个相对的LRR凹陷部位之间的分子接触是由一个从LRR过渡段延伸出来的酸性环介导的。CRID3的结合大大稳定了NACHT和LRR结构域,使结构分辨率达到3.8-4.2埃。它的中心磺酰脲基团与NLRP3核苷酸结合域的Walker A模体相互作用,并夹在两个精氨酸之间,从而解释了NLRP3对这种化学实体的特异性。
 
随着这一先导疗法结合部位的确定,NLRP3的特异性靶向治疗自体炎症和自身免疫性疾病以及合理的药物优化将指日可待。
 
据介绍,NLRP3是一种细胞内传感蛋白,它被广泛的外源性和内源性刺激物激活,导致炎症体的形成和焦亡。NLRP3的构象状态和拮抗性小分子在分子水平上的作用方式仍然不为人所知。
 
附:英文原文
 
Title: Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3

Author: Hochheiser, Inga V., Pilsl, Michael, Hagelueken, Gregor, Moecking, Jonas, Marleaux, Michael, Brinkschulte, Rebecca, Latz, Eicke, Engel, Christoph, Geyer, Matthias

Issue&Volume: 2022-02-03

Abstract: NLRP3 is an intracellular sensor protein whose activation by a broad spectrum of exogenous and endogenous stimuli leads to inflammasome formation and pyroptosis1,2. The conformational states of NLRP3 and the way antagonistic small molecules act at the molecular level remain poorly understood2,3. Here we report the cryo-electron microscopy structures of full-length human NLRP3 in its native form and complexed with the inhibitor CRID3 (also named MCC950)4. Inactive, ADP-bound NLRP3 is a decamer composed of homodimers of intertwined LRR domains that assemble back-to-back as pentamers. The NACHT domain is located at the apical axis of this spherical structure. One PYD dimer is additionally formed inside the LRR cage. Molecular contacts between the concave sites of two opposing LRRs are mediated by an acidic loop extending from an LRR transition segment. Binding of CRID3 significantly stabilizes the NACHT and LRR domains relative to each other, allowing structural resolution of 3.8-4.2 . CRID3 binds into a cleft, connecting four subdomains of the NACHT with the transition LRR. Its central sulfonylurea group interacts with the Walker A motif of the NLRP3 nucleotide-binding domain and is sandwiched between two arginines, explaining the specificity of NLRP3 for this chemical entity. With the determination of the binding site of this lead therapeutic, specific targeting of NLRP3 for the treatment of autoinflammatory and autoimmune diseases and rational drug optimization are within reach.

DOI: 10.1038/s41586-022-04467-w

Source: nature.com/articles/s41586-022-04467-w

Nature:《自然》,创刊于1869年。隶属于施普林格·自然出版集团,最新IF:69.504
官方网址:http://www.nature.com/
投稿链接:http://www.nature.com/authors/submit_manuscript.html


本期文章:《自然》:Online/在线发表

分享到:

0